Dr. Perry serves as a managing director and operating partner at Bioscience Managers, a venture capital firm, as well as adjunct professor at the University of Colorado School of Medicine, Gates Center for Regenerative Medicine and Stem Cell Biology. He recently retired from Novartis, following a highly successful tenure where he held roles of increasing responsibility, most recently serving as senior vice president and chief scientific officer, global BD&L, and Novartis’ observer on the Gamida Cell Board of Directors. Dr. Perry serves as chair of the Translational Medicine Advisory Board of the Houston Methodist Research Institute and is on the board of directors of Avita Medical, Arrowhead Pharmaceuticals and AmpliPhi Biosciences.
Dr. Perry holds an honors bachelor’s degree in physics from the University of Guelph in Ontario, Canada. He also holds a doctorate in veterinary medicine and surgery from the Ontario Veterinary College and a Ph.D. in biomedical science/pharmacology from the University of Guelph.